Metabolic Diseases 2016 Breakthrough Events in Diabetes and Obesity

Event Information

Meeting Type: Physical
Meeting Website:
Dates: December 1 - 2, 2016
Location: Melbourne , Australia
Intended Audience: ,
Sponsor: Monash Biomedicine Discovery Institute; Novo Nordisk
Purpose: Scientific
Number of CME Credits Offered: None

Topics: Adrenal, Cardiovascular Endocrinology, Diabetes Mellitus and Glucose Metabolism, Endocrine Disruption, Adipose Tissue Appetite and Obestity, Neuroendocrinology


Come and join us for the Metabolic Disease 2016 Conference!

Obesity has reached epidemic proportions throughout the developed world and is spreading across Asia, Oceania and Africa. Obesity is a principal factor in overall disease burden in the world and the single most important contributor to the development of type 2 diabetes, a leading cause of morbidity and premature mortality.

This international meeting, with the subtitle “Breakthrough Discoveries in Diabetes and Obesity”, will provide a forum for the exchange of ideas between the academic, clinical and pharmaceutical communities to develop an integrative understanding of pathogenesis and strategies for combating obesity, type 2 diabetes.

The meeting will feature some of the leading international scientists in the obesity and type 2 diabetes fields, including Philipp Scherer (University of Texas Southwestern Medical Center), Joel Elmquist (University of Texas Southwestern Medical Center), Matthew Rodeheffer (Yale School of Medicine), Anton Bennett (Yale School of Medicine) and Scott Summers (University of Utah), as well as some of the very best Australian diabetes and obesity researchers including David James, Michael Cowley, Matthew Watt, Jenny Gunton, Herbert Herzog, Stephen Simpson and Mark Febbraio to name a few.

We look forward to welcoming everyone to the meeting!

Tony Tiganis
Chair, Metabolic Diseases organising committee

Event Contact

Name: Tony Tiganis
Phone: +61 3 99029181
Fax: +61 3 99055645